gp49B1 suppresses stem cell factor-induced mast cell activation-secretion and attendant inflammation in vivo.

Eur J Immunol 2003 Aug;33(8):2262-8

Department of Medicine, Harvard Medical School, Boston, USA.

We report that gp49B1, a mast cell membrane receptor with two immunoreceptor tyrosine-based inhibitory motifs (ITIM), constitutively inhibits mast cell activation-secretion induced by stem cell factor (SCF), a tissue-derived cytokine that also regulates mast cell development. The intradermal injection of SCF into the ears of gp49B1 null (gp49B(-/-)) mice elicited approximately 4- and 2.5-fold more degranulating mast cells and tissue swelling caused by edema, respectively, than in gp49B(+/+) mice. SCF did not induce tissue swelling in mast cell-deficient mice, and the responsiveness of gp49B(-/-) mice to mast cell-associated amine and lipid mediators was unaltered. When gp49B(+/+) and gp49B(-/-) mice were pretreated with antagonists of the amines, SCF-induced tissue swelling was reduced by >90% and 60%, respectively, and it was reduced by >90% in both genotypes when a cysteinyl leukotriene receptor antagonist was also provided. Hence, the dominant contribution of secretory granule amines to SCF-induced tissue swelling is the result of gp49B1-mediated inhibition of the production of cysteinyl leukotrienes by mast cells. Our findings also provide the first example of an ITIM-bearing receptor that constitutively suppresses inflammation generated in vivo independently of the adaptive immune response by a receptor that signals through intrinsic tyrosine kinase activity rather than immunoreceptor tyrosine-based activation motifs.

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.200323978DOI Listing
August 2003

Publication Analysis

Top Keywords

mast cell
16
tissue swelling
16
gp49b-/- mice
12
reduced >90%
8
immunoreceptor tyrosine-based
8
scf-induced tissue
8
mast
8
amines scf-induced
8
cell activation-secretion
8
mast cells
8
stem cell
8
cell
6
mice
5
>90% genotypes
4
mice pretreated
4
gp49b+/+ gp49b-/-
4
mediators unaltered
4
unaltered gp49b+/+
4
pretreated antagonists
4
cysteinyl leukotriene
4

Similar Publications